May 20, 2018
Takeda Pharmaceutical Co. reached an agreement to buy Shire PLC. This ends a long battle for control of the European drugmaker and marks the biggest-ever overseas […]
May 20, 2018
For the first time, DRG Digital’s Manhattan Research asked doctors which pharma companies they trust in its 16th annual Taking the Pulse survey. They asked questions […]
May 20, 2018
The FDA will launch a website to put brand drug manufacturers on notice if they block generic competition as part of President Donald Trump’s plan to […]
May 20, 2018
David Liu has been quietly building a company that will attempt to transform his base editing technique into therapies for numerous genetic diseases. That start-up, Beam […]
May 20, 2018
Scandal erupted when Stormy Daniels’ lawyer, Michael Avenatti, claimed Novartis made “suspicious financial transactions” to President Donald Trump’s personal lawyer, Michael Cohen. Novartis admitted its payments […]
June 22, 2018
Roche will spend $2.4B to buy genomic profiling company Foundation Medicine. The deal will further Roche’s precision medicine plans while allowing Foundation to continue to work […]
June 29, 2018
The FDA approved the country’s first drug derived from marijuana that treats two rare and devastating forms of epilepsy on Monday. The drug, GW Pharmaceuticals’ Epidiolex, […]
July 6, 2018
Kidney disease specialist Akebia Therapeutics will merge with Keryx Biopharmaceuticals in an all-stock deal, creating a $1B company that blends Keryx’s commercial presence in the renal […]
July 6, 2018
The wide gender gap higher up, though improved in recent years, persists in biopharma: Women only hold a quarter of all C-suite level jobs, and less […]